Skip to Main Content

Rise and shine, everyone, another busy day is on the way. And this is an even busier time than usual, thanks to recent intriguing developments. There is only one thing to do, of course, when events threaten to overtake you — fire up the coffee kettle and quaff some cups of stimulation. We are relying on chocolate cherry decadence this morning, for those who track this sort of thing. Meanwhile, here are a few items of interest. Hope your day is interesting and productive. And do drop us a line if you come across anything interesting, such as curious payments to fixers …

President Trump on Friday plans to outline a series of initiatives aimed at curbing drug prices that will be accompanied by proposed rules and a broad request for input from manufacturers, health providers, patients, and others, according to The Wall Street Journal. The administration wants to move some drugs out of Medicare Part B, but the proposals are expected to fall short of earlier ideas backed by Trump, including letting Medicare use its enormous buying power to negotiate drug prices directly with suppliers.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!